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The  lymphocyte function-associated  1 (LFA-1), ~ Mac-l, and p150,95  mole- 
cules constitute a  family of structurally and functionally related, high molecular 
weight, human leukocyte surface glycoproteins (1). Each molecule contains an a 
and a 3 subunit noncovalently associated in an al31 structure. The 3 subunits of 
Mr  95,000  in  each  of these  three  molecules are  identical.  The  molecules are 
distinguished by their a  subunits, which have different isoelectric points, molec- 
ular weights, and cell distributions, and are immunologically non-cross-reactive. 
The relative molecular weights of the  Mac-l,  LFA-1, and p150,95  a  subunits 
are  165,000,  177,000,  and  150,000  for  aM,  aL, and  aX,  respectively.  This 
glycoprotein family is conserved in mouse and human (1, 2). In both species, the 
a  and  3  subunits  of each  molecule  are  biosynthesized as  separate  a'  and  ~' 
intracellular precursors (1, 3). The precursors associate into a'~' complexes, are 
processed to the mature a3 form, and then transported to the cell surface. The 
murine aM and aL subunits have 33% amino acid sequence homology with one 
another. 2 Such  homology suggests that a  primordial  a  chain gene duplication 
event(s) led to the evolution of this glycoprotein family. 
The  LFA-1  and  Mac-1  molecules contribute  to multiple types of leukocyte 
adhesion reactions. The LFA-1  molecule participates in the formation of adhe- 
sions between effector and target cells in cytolytic T  lymphocyte-mediated killing 
and in natural killing, as shown by monoclonal antibody (mAb) blocking experi- 
ments (4-6).  LFA-1 also participates in T  helper cell responses, and its distribu- 
tion on B cells, granulocytes, and monocytes suggests it may function in adhesion 
of these  cells  as  well  (7).  Mac-1  has  been  defined  (8)  by  mAb  as  a  mouse 
differentiation antigen present on myeloid and absent on lymphoid cells. Subse- 
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quently, human Mac-1  was identified by cross-reaction of an mAb with mouse 
Mac- 1 (9), and the OKM 1, Mo 1, OKM9, and OKM 10 mAb to other determinants 
on human Mac-1  were obtained (10,  11).  Mac-1  appears to be identical to the 
complement receptor type 3 (CR3). The CR3 binds the inactivated form (iC3b) 
of the third component of complement and mediates adherence and phagocytosis 
of iC3b-coated particles by granulocytes and monocytes. Some mAb to  Mac-1 
inhibit the CR3 on myeioid cell surfaces (10, 12, 13). Furthermore, Staphylococcus 
aureus-mAb-Mac-1  complexes  formed  with  noninhibitory  mAb  and  soluble 
Mac-1 specifically agglutinate iC3b-opsonized erythrocytes (10). 
Patients with a  clinical syndrome characterized by recurrent bacterial infec- 
tions, progressive periodontitis, delayed wound healing, persistent granulocyto- 
sis, and/or delayed umbilical cord separation have been described (reviewed in 
14).  Granulocytes and  mononuclear leukocytes of these patients  demonstrate 
severe abnormalities of adherence and functions dependent on adherence, in- 
cluding phagocytosis and motility (13-18).  When total surface-labeled granulo- 
cyte proteins  from  these  patients  were subjected  to  sodium dodecyi sulfate- 
polyacrylamide gel electrophoresis (SDS-PAGE) (14,  17-19),  a  deficiency was 
recognized of a  glycoprotein(s) variously  estimated  at  110,000-180,000  Mr. 
Subsequently (14,  20,  21),  deficiency of a  specific surface molecule was  pin- 
pointed using anti-Mac-l, Mol, and OKM1  mAb to the Mac-1  a  subunit. The 
Mac-1  /3 subunit was also found deficient using the TS1/18 mAb (14, 20). 
In the present report, a  group of unrelated patients and their kindreds was 
examined to determine the genetic and molecular basis of this disease. Previous 
knowledge (1) about  the subunit  organization of the  Mac-l,  LFA-1,  p150,95 
glycoprotein family has been  important  in  guiding investigations.  Since these 
molecules share a  common/3 subunit,  the possibility of a  deficiency of LFA-1 
and p150,95  as well as of Mac-l,  was  tested with subunit-specific mAb.  The 
mode of inheritance of this disorder in the kindreds studied and possible variation 
among patients in the severity of deficiency at the cell surface were examined by 
quantitative imunofluorescence flow cytometry. Finally, the molecular basis of 
the defect was probed by immunoprecipitation of both cell surface molecules 
and  their intracellular precursors.  A  novel,  heritable deficiency of the entire 
Mac-l,  LFA-1  glycoprotein family is described. The findings sugg6st  that the 
primary  defect  is  in  the  common  /3  subunit.  The  presence  of a  normal  a' 
intracellular precursor suggests that the lack of both a and/3 subunits on the cell 
surface reflects a  requirement of formation of a'/3'  complexes for processing 
and transport to the surface. 
Materials and Methods 
Patients.  Four kindreds were studied. Kindred I included a 6-yr-old Caucasian female 
patient and her parents (14). Kindred 2 included a 15-too-old Mexican-American female 
patient, her 3- and 5-yr-oid brothers, and her parents.  Kindred 3 consisted of the parents 
of a 17-mo-old deceased Iranian female patient. Kindred 4 included a 17-yr-old Mexican- 
American male patient,  his 21-yr-old sister, and mother (15). Each patient manifested 
recurrent soft tissue infections, progressive periodontitis,  impaired wound healing, and 
persistent  granuiocytosis.  Three of four patients  demonstrated delayed umbilical cord 
separation.  Severe deficits of leukocyte mobilization in vivo (Rebuck skin window) and 
leukocyte motility in vitro (Boyden chamber assay) were identified in each patient. Among SPRINGER  ET  AL.  1903 
other family members of each kindred, no infectious susceptibility, impairment of wound 
healing, or other clinical  diseases were recognized. Assessments of leukocyte functions 
among the latter individuals were generally normal. 
Monoclonal Antibodies.  Anti-aL mAb were either TS1/22 or an equal volume mixture 
of TS1/12, TS2/14, TS1/22, TS2/4, and TS2/6 culture supernatants (1). Anti-/3 mAb 
was  TS1/18 (1); anti-aM  mAb were OKMI,  OKM10  (11) (kindly provided by Dr.  G. 
Goldstein), or M1/70 (9). F(ab')2 rabbit anti-CR1  (22) was a kind gift of Dr. D. Fearon; 
mouse mAb 44D to CR1 (23) was kindly given by Dr. V. Nussenzweig. mAb to HLA was 
W6/32 (24). Antineutrophil FcR mAb 3G8 (25) was kindly provided by Dr. J. Unkeless. 
Leukocytes.  Blood was drawn and transported in syringes containing citrate/phosphate/ 
dextrose/adenine anticoagulant.  Red blood cells (RBC) were sedimented with 20% (by 
volume) of 6%  Dextran T-500 (Pharmacia Fine Chemicals,  Piscataway, NJ) for 20-30 
min at 20 ° C. All remaining steps were at 4 ° C to avoid "up-regulation" of surface receptors 
triggered by cell purification (26). Granulocytes and mononuclear cells were isolated by 
centrifugation for 25 min at 1,200 g on Ficoll-Hypaque layers oft/= 1.106 and 1.08 (27) 
or on a single layer of d --- 1.08 (14). For radiolabeling experiments, RBC contaminating 
the granulocytes were lysed with H~O for 20 s. Cells were washed three times in phosphate- 
buffered saline (PBS) or Hanks'-Hepes +  5 mM EDTA. 
B and T Cell Lines.  To establish Epstein-Barr virus (EBV) transformants,  106 mono- 
nuclear cells/ml in RPMI  1640, 20% fetal calf serum (FCS), and 50 #g/ml gentamycin 
were incubated for 16 h  with EBV-containing supernatant of B95-8 cells (28) (kind gift 
of Dr.  D.  Thorley-Lawson), 6.25% TS1/8 anti-LFA-2 supernatant,  and 0.625%  Leu-4 
ascites (kindly provided by Dr.  R.  Evans).  Cells  in 0.2-ml aliquots were placed into  10 
microtiter wells.  Medium  was  replaced  with  RPMI  1640,  20%  FCS,  and  50  #g/ml 
gentamycin until cell growth was noted. Cells grew in most wells and were expanded in 
the same medium. Phytohemagglutinin (PHA) blasts  were established at  106 cells/ml in 
RPMI  1640, 20% FCS containing a  1:800 dilution of PHA-P (Difco Laboratories, Inc., 
Detroit, MI).  PHA lines were expanded with interleukin 2 (IL-2)-conditioned medium 
and pulsed weekly with PHA (29). 
Immunofluorescence  Flow Cytometry.  Cells were labeled with one of the following: anti- 
aL mAb TS 1/22, the mixture of five anti-aL mAb hybridoma supernatants, anti-/3 mAb 
TS 1  / 18 hybridoma supernatant, anti-aM mAb (20 #g/ml of purified OKM 1 or OKM 10), 
anti-CR1  mAb (20 #g/ml of purified 44D or 5 #g/ml of F(ab')~  rabbit anti-CRl), anti- 
HLA W6/32 mAb hybridoma supernatant, antineutrophil FcR 3G8 hybridoma superna- 
tam, or, as control, P3X63.Ag8 ~,K myeloma culture supernatant.  After washing,  they 
were stained  with  fluorescein isothiocyanate (FITC)-labeled affinity-purified goat anti- 
mouse IgG, 70 #g/ml (Zymed, Burlingame, CA), as described (30).  Flow cytometry was 
done with an Epics V (Coulter Electronics, Inc., Hialeah, FL). Both linear and logarithmic 
scatter-gated fluorescence histograms were collected. Peak positions were either deter- 
mined from linear histograms or determined from logarithmic histograms and converted 
to linear values with a log-linear calibration curve (30). The peak position of the control 
was subtracted to calculate specific fluorescence intensity. 
Radiolabeling.  Granulocytes (107 in 0.5 ml of Dulbecco's PBS, 0.2% glucose, 10 mM 
Hepes) were labeled by the addition of 0.625  U/ml  glucose oxidase (from Aspergillus 
niger,  type V;  Sigma  Chemical  Co.,  St.  Louis,  MO),  0.125  U/ml  of centrifuged and 
resuspended  crystalline  lactoperoxidase  (Boehringer  Mannheim,  Federal  Republic  of 
Germany), and 5 mCi Na12~I (New England Nuclear, Boston, MA), followed by incubation 
o  6  for 15 min at 20  C with occasional swirling. PHA and EBV lines (1.5-15 ×  10  cells in 5 
ml) were labeled with 1 mCi [sSS]methionine (New England Nuclear) in methionine-free 
RPMI 1640, 20% dialyzed FCS, 10 mM Hepes, 50 #g/ml gentamycin, and, for PHA lines 
only, 2% dialyzed IL-2-containing conditioned medium, for 2 h at 37°C in duplicate 100- 
mm petri dishes. Cells  from one dish were chased for 22 h at 37°C in complete RPMI 
1640 medium, 20% FCS (with 2% IL-2 for PHA lines) after one wash with warm medium. 
At the end of the pulse or chase, cells were washed once in cold PBS and lysed. 
Immunoprecipitation.  Cells  were lysed in  1% Triton X-100,  1% bovine hemoglobin, 
0.14 M NaC1, 0.01 M Tris HCI, pH 8.0, with freshly added 1 mM phenylmethylsulfonyl 1904  INHERITED  DEFICIENCY  OF  Mac-l,  LFA-I,  p150,95 
fluoride, for 20 min at 4°C, and centrifuged at  10,000 g for 10 min. Supernatants  were 
precleared by addition of 10% (by volume) each of suspensions of 10% S. aureus bacteria 
and 50% cyanogen bromide (CNBr)-activated,  glycine-quenched Sepharose. Lysates were 
then centrifuged at 10,000 g for 10 rain, and supernatants  ultracentrifuged at 150,000 g 
for  30  rain.  Additionally,  for  [sSS]methionine  lysates,  stock  solutions  of  5%  sodium 
deoxycholate, 20% Triton X-100, and 10% SDS were added to bring the final concentra- 
tion to 1% Triton X- 100,  1% deoxycholate, 0. ! % SDS. Lysates were incubated overnight 
at 4 °C and subjected to a second preclearing and uitracentrifugation. For immunoprecip- 
itation, lysates (25-50 #1) were mixed with 10 #1 of a 50% suspension of mAb-Sepharose 
CL-4B, coupled at 2 mg/ml, or 50 tA of either hybridoma supernatants  or purified mAb 
at  100 #g/ml.  Precipitates of soluble mAb were formed with 10 #1 of rabbit anti-mouse 
IgG serum and 50 #1 of 10% S.  aureus.  Precipitates were washed and subjected to SDS- 
PAGE (31) and autoradiography with enhancing screens (32) or fluorography (33). 
Results 
mAb specific for the LFA-1  and Mac-1  aL and aM subunits, and the common 
/3 subunit,  were used in immunofluorescence  flow cytometry studies of patients' 
granulocytes  (Fig.  1).  Saturating  concentrations  of mAb and second  FITC anti- 
mouse  IgG  reagents  were used.  Under  these  conditions,  fluorescence  intensity 
(after subtraction of background  fluorescence) is proportional  to the number of 
mAb-binding  (antigen)  surface sites per cell (30).  Three unrelated patients  with 
recurring  bacterial  infections  were  strikingly  deficient  in  the  Mac-1  a  subunit 
(Fig.  1,J-L).  Furthermore,  the LFA-1  ez subunit (Fig.  1, F-H) and the common 
/3  subunit  (Fig.  1,  N-P)  were  deficient.  Thus,  not  only  Mac-I  but  also  other 
molecules sharing  its/3 subunit  were affected.  Interestingly,  there  were quanti- 
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FIGURE  l.  Immunofluorescence flow cytometry ofgranulocytes from patients with recurring 
bacterial infections. Granulocytes were indirectly stained with F(ab')2 rabbit anti-human CR 1, 
TSI/22 anti-LFA-1  a, OKM1 anti-Mac-1 a, or TS1/18 anti-B mAb (solid curves); or control 
P3X633'/K (dashed curves). SPRINGER  ET  AL.  1905 
tative differences among the patients in the severity of deficiency. Patients 1 and 
2 expressed an average of between 0.2 and 0.5% of the normal amounts of the 
three subunits. These patients' cells consistently showed slight staining with the 
specific mAb relative to irrelevant control mAb (see also Figs. 2, 4, and 5 below), 
indicating that the subunits are actually expressed, but at extremely low levels. 
In contrast to patients  1 and  2,  patient  4  expressed distinctly higher but still 
markedly deficient amounts,  3,  9,  and  7%  of the  aL,  aM,  and  /3  subunits, 
respectively. The deficiency in LFA-1 and Mac-1 did not reflect the lack of only 
one or a  few antigenic determinants,  since deficiency of the aL  subunit  was 
confirmed with five mAb recognizing four spatially distinct epitopes (34), and 
since deficiency of aM was found with M 1/70, OKM 1, and OKM 10 mAb, which 
bind to three different epitopes (11 and unpublished results). Binding assays with 
~5I-labeled anti-aL and/3 F(ab')2 fragments and anti-aM mAb gave the same 
results for patients  1,  2, and 4  (data not shown). In contrast, the complement 
receptor type I  (CR1) (Fig.  1, B-D),  neutrophil  FcR, and  HLA antigens (not 
shown), were present on patients' cells in normal amounts. 
Next, the effect of chemotactic factors on the expression of the Mac-l, LFA- 
1 family on normal and patient cells was examined. N-formylmethionyl peptides 
bind  to  specific receptors,  and  stimulate  granulocyte adherence, chemotaxis, 
granule secretion, and the mobilization of f-Met-Leu-Phe and CR1  receptors 
from latent intracellular pools to the cell surface (26, 35). Importantly, specific 
and saturable  binding of f-Met-Leu-Phe by granulocytes of patients  with  this 
disorder  has  previously  been  shown  to  be  normal  (14,  15).  f-Met-Leu-Phe 
stimulated a dramatic increase in aM and/3 subunit surface expression on healthy 
adult control granulocytes (Fig. 2, compare b and c to e and f). Similar relative 
increases were observed on parental granulocytes, although the absolute amounts 
of surface expression were lower than on control cells (Fig. 2, compare h and i 
to k and l; n and 0 to q and r). Average increases for two controls and two sets 
of parents were 5.5- and 3.7-fold for aM and/3, respectively. The increases for 
LFA-1  a  were consistently lower,  1.35-fold for both parental and control cells. 
Patient granulocytes, in contrast, did not express a latent pool of aM,/3, or aL 
(Fig. 2, y-dd); patients  1 and 2 expressed _< 1% of normal amounts after f-Met- 
Leu-Phe stimulation. Similar increases in parents, and deficiency of a latent pool 
in patients, were observed with granulocytes stimulated with the chemoattractant 
C5a at 20°C relative to control cells held at 20°C (data not shown). In contrast, 
patient and parental granulocytes demonstrated normal increased surface expres- 
sion (about sixfold) of CR1 (not shown), as previously reported for healthy adult 
granulocytes (26). 
To detect heterozygotes and to examine the mode of inheritance, expression 
on cells of parents and siblings was quantitated. Granulocytes of a representative 
father and mother (Fig. 2, g-r) expressed an amount of aM and/3 intermediate 
between that on healthy control and patient cells. Levels of  expression on parents, 
siblings, and patients relative to healthy adult controls are summarized in Fig. 3. 
The data are averages of two to four separate determinations on unstimulated 
granulocytes prepared  at  4°C,  each  expressed as  a  percent of healthy adult 
controls. When mothers and fathers were separately averaged, mean values for 
maternal cells were 53-66%  for the three subunits;  mean values for paternal 1906  INHERITED  DEFICIENCY  OF  Mac-l,  LFA-1,  p150,95 
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FIGURE 2.  Mac-l, LFA-1 expression on patient and family member granulocytes, before or 
after f-Met-Leu-Phe activation. Granulocytes (107/ml) in  Hanks'-Hepes, 5  mM EDTA were 
incubated with  10  -8 M f-Met-Leu-Phe for 30 min at 37°C or were held at 4°C. They were 
then subjected to immunofluorescent labeling and flow cytometry. Cells were stained with a 
mixture of five anti-LFA-1 c~ mAb, TS1/18  anti-B  mAb, or OKM1 anti-Mac-1 c~ mAb (solid 
curves); or P3X63 control IgG1  (dashed curves). 
_e 
8 
oo  100 
=- 
._= 
.,J A 
----  75 
i. v 
o  25 
I,I. 
c  = 
0 
LFA1 
___lJ  ....... 
"l 
•1 
-r 
sl 
Patient 
Sibling 
Parent 
OKMlo~ 
Male  Female 
•  o 
,£  ° 
CR1 
•  B 
t 
cl 
3 
FIGURE  3.  Expression of Mac-l,  LFA-1, and  CR1  on  unstimulated granutocytes of four 
affected kindreds. Fluorescence intensity due to specific antibody binding was calculated as 
described in  Materials and Methods and expressed as a percentage of healthy adult control 
values. Averages of two to four determinations are plotted for each individual. SPRINGER ET  AL. 
TABLE  I 
Expression of Mac-I a and [J on f-Met-Leu-Phe-stimulated  Parental Granulocytes 
1907 
Fluorescence intensity (percent of normal control) 
Kindred 1 
Exp. 1  Exp. 2 
Kindred 2  Kindred 3  Average 
Father 
Mother 
Mac-1 
a  43  44  61  54  50 
47  74  60  61  61 
Mac-1 
a  61  56  77  ND  65 
74  61  81  ND  72 
cells were 58-63%.  Two male siblings appear  to be normal  homozygotes and 
one female sibling appears to be a  heterozygote (Fig.  3).  A  smaller number of 
measurements  were  also  made  on  f-Met-Leu-Phe-stimulated  cells  (Table  I). 
Again,  both maternal  and paternal  granulocytes expressed amounts of antigen 
intermediate  between  patient  and  normal  cells,  further  suggesting  they  are 
heterozygous.  Granulocytes were more homogeneous in fluorescence intensity 
after  stimulation  (Fig.  2,  compare  le~  and  right).  Overall,  less  variation  was 
apparent  in  measurements  on stimulated  cells, perhaps  because differences in 
cell  activation  in  vivo,  or  those  related  to  handling  or  transportation,  were 
minimized.  Assessment of surface expression  under  stimulated  conditions may 
allow more accurate identification of heterozygotes. The parent with the highest 
level of subunit expression on unstimulated granulocytes was a father with 90% 
of the  normal  amount  of Mac-1  a;  the  value  on  stimulated  granulocytes  was 
44%. 
Other leukocyte lineages were examined to determine whether Mac-l, LFA-1 
deficiency was generalized or was related to cell differentiation.  Normal mono- 
nuclear cells are a mixture of LFA-1 + Mac-l- lymphocytes and LFA-1 + Mac-1 + 
monocytes (7) and express considerably higher levels of LFA-1 than granulocytes. 
Patient  1 mononuclear cells were clearly deficient in aL,/3, and aM (Fig. 4, d- 
f), as were mononuclear cells of patient 2 (data not shown). Although patient 4 
mononuclear cells were not examined by immunofluorescence, 12~I-labeled mAb 
binding  showed  4,8  and  4.6%  of normal  amounts  of the  aL  and  /3 subunits, 
respectively. 
PHA-activated T  lymphoblasts and  EBV-transformed  B  lymphoblastoid cell 
lines  were  established  from  patients  as  continuous  sources  of experimental 
material and to allow characterization of antigen expression on T  and B lympho- 
cyte lines.  Normal PHA blasts and EBV lines expressed LFA-1  ot and 13 (Fig.  5, 
a, b, e,f) and were Mac-1  a- (not shown).  PHA blasts expressed 2.3-fold more 
LFA-1  than  EBV  lines.  LFA-1  a  and  13 were deficient  in  both  the  T  and  B 
lymphoblast lines (Fig.  5,  c,  d,  g-l).  For patient  4,  the deficiency of aL and  13 
appeared  more severe on the  EBV line  than  on granulocytes or mononuclear 
cells. 
To examine  the  deficiency at a  molecular  level,  granulocytes were surface- 1908  INHERITED  DEFICIENCY  OF  Mac-l,  LFA-1,  p150,95 
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FIGURE 6.  Immunoprecipitation of ~251-1abeled surface proteins from granulocytes. Triton 
X-100 lysates of each individual's ~SI-labeled granulocytes were immunoprecipitated with a 
mixture of five different anti-LFA-1  a  mAb (lane  I), anti-LFA-1  a  TS1/22 mAb-Sepharose 
CL-4B (lane 2), anti-/3 TS 1/18 mAb-Sepharose (lane 3), anti-OKM 1 mAb (lane 4), or anti-CR 1 
44D mAb (lane 5). Precipitates were subjected to SDS-7% PAGE and autoradiography. 
labeled with 125I and subjected to immunoprecipitation and SDS-PAGE (Fig. 6). 
From healthy adult cells, the anti-aL mAb precipitated the LFA-1  aL subunit 
noncovalently associated with its/3 subunit  (Fig.  6A,  lanes  I  and 2).  Anti-aM 
mAb precipitated the aM subunit with its/3 subunit (Fig. 6A, lane 4). The anti- 
/3 mAb precipitated the/3 subunit and the three types of a subunits noncovalently 
associated with it:  aL, aM, and the aX subunit of the p150,95  molecule (Fig. 
6 A, lane 3). In contrast, granulocytes from three patients were strikingly deficient 
in all these molecules (Fig. 6, B, G, K, lanes 1-4). Parents and normal siblings of 
the patients were positive for immunoprecipitation (Fig. 6, C-F, H, I, L, M, lanes 
1-4). The CR1  molecule was precipitated as a positive control; it was present in 
similar amounts in  granulocytes of healthy adults,  patients,  and their kindred 
(Fig. 6, A-N, lane 5). Normal amounts of HLA antigen and neutrophil FcR were 
also precipitated from patients' cells (not shown). 
In an attempt to detect low levels of expression on patient cells, autoradiograms 
were subjected to prolonged exposure. Precipitation of small amounts of LFA-1 
were detected in patient 4 (Fig. 6 O, lanes 2 and 3) but not in patients  I  and 2, 
findings  consistent  with  the  immunofluorescence cytometry results.  Notably, 
anti-aL and anti-/3 mAb each precipitated both a and/3 subunits. This shows that 
when surface expression can be detected on patient cells, it is due to the presence 
of the normal a/3 complex, rather than to the presence of unassociated a  or/3 
subunits. 
The  biochemical  basis  for  the  lack  of surface  expression  was  studied  in 
biosynthesis experiments. The lack of LFA-1  and p150,95  as well as Mac-1  on 
patients'  cells suggested the primary deficiency was in the common/3 subunit. 
Although both a  and/3 subunits were lacking on the cell surface, it was hypoth- 
esized  that  normal  intracellular  a  precursors  might  be  present,  but  require 
association with/3 for transport to the surface. To test this hypothesis, PHA and 
EBV lines were pulsed with [35S]methionine to label precursors, and then either 1910  INHERITED  DEFICIENCY  OF  Mac-l,  LFA-1,  p150,95 
examined immediately or chased with cold methionine to examine processing 
and maturation. 
In healthy adult PHA blasts and EBV-transformed cells, large amounts of an 
0~'L precursor and small amounts of mature aL were detected after a 2-h pulse 
by immunoprecipitation with anti-otL mAb (Fig.  7, A and C,  lane  1).  Subunit 
association preceded processing, as shown by precipitation of a'L  with anti-/3 
(Fig.  7, A and C,  lane 3), and precipitation of all the aL produced during the 
pulse with anti-/3 (Fig. 7, A and C; compare similar amounts of aL in lanes 1 and 
3).  After the 22-h chase, the mature aL and/3 subunits were found, and were 
associated with one another, as shown by precipitation  with both anti-aL and 
anti-/3 mAb (Fig. 7, A and C, lanes 2 and 4). A/3' precursor was not identified by 
precipitation in this or four other independent labeling experiments, suggesting 
it had weak reactivity with the mAb and/or migrated in the same position as a 
background band. 
In  cells  from  all  three  patients,  normal  amounts  of the  intracellular  ot'L 
precursor were identified by precipitation with anti-aL mAb (Fig.  7, B, D, and 
E,  lane  1).  The  o~'L precursor never matured,  however, as demonstrated by 
precipitation of small amounts of a'L but not aL after the 22-h chase (Fig. 7, B, 
D, and E, lane 2). The lack of precipitation of a'L by anti-/3 mAb showed it did 
not become/3 associated, nor was there any evidence of the mature/3 subunit 
(Fig.  7,  B,  D, and E,  lanes 3  and 4).  Patient and control a'L were present in 
similar amounts after the 2-h pulse (Fig.  7, A-E, lane 1), suggesting they have 
equal stability. The a'L precursor was largely degraded in patients' cells after 
the 22-h  chase, showing intracellular,  unassociated a'L  has a  shorter half-life 
than extracellular, associated aL, as would be expected. These findings (a) show 
that the patient lymphocytes have normal a'L precursors, (b) suggest that they 
lack normal/3' precursors, and (c) suggest that ot'L cannot be processed normally 
and  transported  to  the  cell  surface in  the absence  of association  with  the  /3 
subunit. 
Discussion 
An entire family of glycoproteins that share a common/3 subunit, Mac-l, LFA- 
1, and p150,95, has been found to be deficient on leukocyte surfaces in patients 
with recurring bacterial infections. Surface deficiency of the a and/3 subunits of 
these molecules was independently investigated with mAb to the o~L, aM, and/3 
subunits. Since these mAb have previously been demonstrated (1) to react with 
125I surface-labeled subunits dissociated by brief exposure to high pH, any free 
subunits present on the surface of patients' cells should have been detectable. 
Both the o~L and/3 subunits of LFA-1, and the aM and/3 subunits of Mac-l, were 
lacking on the cell surface. This was shown by immunofluorescence, 125I-mAb 
binding,  and  immunoprecipitation  of  125I-labeled  surface  molecules.  The 
p 150,95 molecule's 0¢X and/3 subunits were not detected by immunoprecipitation 
with anti-/3 mAb; thus at least its/3 subunit is deficient. By analogy to LFA-1 and 
Mac-l, one would not expect free p150,95 aX subunits to be present on the cell 
surface, but this remains to be directly demonstrated. 
The deficiency appears to be limited to this glycoprotein family. The results 
could not be explained by a pleiotropic effect on high molecular weight proteins F
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or on glycoproteins, since the CR1, the neutrophil Fc receptor, and HLA antigen 
glycoproteins were present in normal amounts and were of normal mobility in 
SDS-PAGE. Normal numbers of f-Met-Leu-Phe receptors, and normal granule 
secretion triggered by receptors for f-Met-Leu-Phe and C5a,  have previously 
been described on these patients' cells (14,  15).  Furthermore, latent CR1  (26) 
and FcR but not aM or/3 were present in patients' granulocytes and could be 
expressed on the surface in response to f-Met-Leu-Phe or C5a. 
A number of lines of evidence show that Mac-1, LFA-1, p150,95 deficiency is 
a heritable autosomal recessive disease, (a) Mothers and fathers in these studies 
were found to express approximately half the normal amount of aL, aM, and/3 
subunits, both on unstimulated and f-Met-Leu-Phe-stimulated granulocytes. (b) 
In the case of X-linked inheritance, two populations (normal and defective) of 
maternal granulocytes would be expected as a result of X chromosome inactiva- 
tion, as is observed in the X-linked form of chronic granulomatous disease (36). 
However, all four mothers had a  single population of granulocytes expressing 
intermediate  levels  of each  glycoprotein subunit.  (c)  One  recently identified 
family contains a  cluster of an affected father, son, and daughter (not shown). 
(d)  Unaffected male  siblings  of a  female  patient  (kindred  2)  and  a  female 
heterozygote sibling of a male patient (kindred 4) were recognized. (e) Equivalent 
numbers of male and female patients have been identified. (f) One patient (No. 
2) was the product of a  consanguinous marriage.  It is interesting that of two 
apparently similar patients in  whom expression was studied by SDS-PAGE of 
total granulocyte proteins and by radioimmunoassay, one was reported to have 
X-linked and the other somatic inheritance (17,  19,  37).  Potentially, polymor- 
phism in the level of expression could make some fathers (or mothers) appear 
normal.  Further studies of the granulocytes of the carrier of the putative X- 
linked defect by immunofluorescence cytometry, for evidence of mosaicism in 
Mac-l,  LFA-1  expression,  would  be  of interest  to  provide  more  convincing 
evidence of X-linked inheritance. 
The molecular pathogenesis of this deficiency was examined in biosynthesis 
experiments.  In  normal  myeloid  ceils,  the  precursors  for  each  subunit  are 
synthesized separately and become noncovalently associated in cq¢31 complexes 
(1),  as shown in  Fig.  8.  In patients'  cells, the a'L  subunit  was synthesized in 
normal amounts and had normal stability, suggesting the primary defect was in 
Chain  CHO 
Association  Processing 
a L  -u  ~ a LI/3t  ~ aL,/31  • 
Transport 
Surface 
~---Block in LFA-I, Mac-1  Deficiency 
FIGURE 8.  Biosynthesis of the Mac-I, LFA-l glycoprotein family. The biosynthetic pathway 
in normal cells is as described  in reference 1. The evidence  for a primary block in 3 subunit 
synthesis, a secondary  block in a'L biosynthesis due to lack of/3 subunit association, and 
hypothetically  similar blocks in a'M and a'X biosynthesis,  is discussed  in the text. SPRINGER ET AL.  1913 
the  3  subunit.  Despite  five  independent  labeling  experiments  and  different 
solubilization  conditions,  the 3'  precursor could not  be  identified in  healthy 
adult or patient PHA blasts or EBV lines. 3' has been previously identified in 
the  U937  myeioid cell  line  (1).  The  difficulty in  identifying 3'  in  B  and  T 
lymphocyte lines may be related to the lower amount of 3 on the cell surface or 
differing glycosylation than in  U937,  or to lower mAb affinity for 3'  than 3. 
Nonetheless, the following lines of evidence strongly suggest that the primary 
deficiency is of the 3 subunit: (a) the presence of normal a'L but absence of any 
form of aL3 complex either at the cell surface or as an intracellular precursor 
detectable by precipitation of aL or a'L by anti-3 mAb, and (b) the lack of three 
different surface proteins having as their only common structural entity the 3 
subunit. 
The  effect of 3  deficiency on  biosynthesis of the  Mac-l,  LFA-1  family is 
summarized in Fig. 8. The presence of a'L precursor but no aL inside patients' 
cells, and the absence of cell surface aL, show that association with the 3 subunit 
is required for processing and transport to the surface. Biosynthesis experiments 
have been done thus far in cells that express only LFA-1, but since the biosyn- 
thetic pathways of Mac-l, p150,95, and LFA-1 are similar in normal cells (1), it 
is proposed that a'M and a'X intracellular precursors are blocked at the same 
point in their biosynthetic pathway in patient myeloid cells, as shown in Fig. 8. 
The lack of at least two and probably three a  subunits on the cell surface as 
the result of 3 subunit deficiency represents an interesting example of the effects 
of gene complementation on the phenotypic expression of an inherited defect. 
The lack of a latent pool of Mac-1  a and 3 in patients' cells suggests that subunit 
association is also required for entry into this pool, which is presumably intracel- 
lular. Studies with endoglycosidase H  digestion of Mac-1  have shown that the 
maturation of a'M to aM is due to the conversion of high mannose to complex- 
type carbohydrates (Kishimoto, Sastre, and Springer, unpublished results). This 
type of carbohydrate processing is known to occur in the Golgi, suggesting that 
lack of association with 3 in patients' cells blocks transport to the Golgi. Further 
understanding of the nature of the mutation, and of whether mRNA is quanti- 
tatively or qualitatively defective, will  be dependent on DNA probes.  In vitro 
translation assays and specific mRNA purification have been developed in the 
mouse  system (38),  and  cross-hybridization  with  cloned  mouse  DNA  probes 
should allow analysis of the defect in human cells. 
Other patients appear to resemble the three described here in lacking multiple 
members of the Mac-l, LFA-1  glycoprotein family. Although patient 3 of this 
study died before testing with mAb, approximately half-normal expression of a 
and 3 subunits by her parents' granulocytes suggests she also suffered from the 
same disease. Four additional patients recently studied by us are also deficient in 
the entire Mac-I, LFA-1 family. Two patients in the eastern United States have 
deficiencies demonstrated with the M1/70 and Mol anti-Mac-1 mAb, the TS1/ 
18  anti-3  mAb,  and anti-LFA-1  mAb (20,  21,  37).  A  patient  in  the western 
U. S. is deficient, as shown with an mAb of undefined subunit specificity but that 
appears similar to our TS1/18 anti-3 mAb (39).  This patient is also unreactive 1914  INHERITED DEFICIENCY OF  Mac-l, LFA-1, p150,95 
with the TS 1/22 anti-aL and OKM 1 anti-aM mAb. Three patients in England 3 
and one in France 4 are deficient in aL, aM, and/3, as demonstrated by TS1/22, 
OKM 1, and TS1/18  mAb. Although  none of these patients have been charac- 
terized by biosynthetic labeling of precursors, and surface 125I-labeled  molecules 
have been characterized  not at all or not to the same extent as in this  report, 
findings in each case are suggestive of a similar defect. 
Heterogeneity with respect to the severity of clinical illness and/or abnormal- 
ities of leukocyte functions observed among recognized examples of this disease 
may be causally related to quantitative differences observed among the patients 
studied here in surface expression of this critical glycoprotein family. Granulo- 
cytes of patient  4  have  ~5%  of normal  amounts  on  the  cell  surface,  and  a~ 
complexes  were  detectable  by immunoprecipitation.  Patients  1 and  2  have  a 
clearly more severe, but apparently not complete, deficiency. Among our patient 
population,  patient  4 appears to have had a  relatively milder clinical disease as 
compared with the other patients  and has survived the disease longest.  Differ- 
ences with respect to the severity and types of functional abnormalities, including 
differences  in  CR3  activity,  observed  between  our  patient  1  and  a  patient 
reported  by Arnaout  and  coworkers (20),  may be related to a  more complete 
Mac-l,  LFA-1, p150,95  deficiency in the former patient  (14).  Collectively, the 
accrued evidence suggests that  with the possible exception of the patient  with 
the X-linked defect (17, 37), the patients reported to date represent examples of 
the  same  genetic  disease.  Despite  some  observed  heterogeneity,  remarkably 
similar clinical  features, functional abnormalities,  and biochemical defects have 
been described among all recognized individuals.  However, the possibility exists 
that  disease  among  different  recognized  kindreds  results  from  independent 
mutations within or affecting the same gene. This is suggested by the quantitative 
variations in surface expression and the different ethnic backgrounds among the 
patients in this report.  Patient  1 is of Anglo-Saxon descent while the parents of 
patient 2 emigrated from Iran.  Patients 3 and 4 (and four other patients) are of 
Hispanic descent;  families of each of these patients  are  living in  or  riginated 
from southern and western Texas. 
Since a  deficiency of the  Mac-I,  LFA-1  family has been clearly documented 
here on multiple types of leukocytes, including granulocytes, monocytes, and T 
and  B  lymphocytes, the  observed functional  abnormalities  of both phagocytic 
and  lymphoid cells of these  patients  (15)  are  not  unexpected.  Recurrent  soft 
tissue  infections  secondary  to  both  bacterial  and  fungal  microorganisms  are 
unquestionably related to granulocyte dysfunction in this disorder. Patient gran- 
ulocytes are  deficient  in  adhesion-dependent  functions,  including  attachment 
and spreading, aggregation, antibody-dependent cytotoxicity, and CR3-mediated 
3 Ross, G. D., R. A. Thompson, M.J. Walport, T. A. Springer, J. V. Watson, R. H. R. Ward, J. 
Lida, S. L. Newman, R. A. Harrison, and P. J. Lachmann. Identification of a genetic deficiency  of 
leukocyte membrane complement receptor type 3 (CR3, an iC3b receptor) and its association with 
increased susceptibility  to bacterial infections. Manuscript submitted for publication. 
4 Fischer, A., R. Segar, A. Durandy, B. Grospierre, J. L. Virelizier, C. Griscelli, E. Fischer, M. 
Kazatchkine, M. C. Bohler, B. Descamps-Latscha, P. H. Trung, D. Olive, and C.  Mawas. 1984. 
Deficiency of the adhesive protein complex LFA-1, C3bi complement receptor, p150,95, in a girl 
with recurrent bacterial infections. Manuscript submitted for publication. SPRINGER  ET  AL.  1915 
adherence and phagocytosis (14,  15,  17,  39). 3'4 Deficiency of CR3  function as 
measured with iC3b-opsonized particles agrees with the previous identification 
of Mac- 1 as the CR3 (10, 12). The wide spectrum of other adhesion abnormalities 
may be  related  to  all  three  members of this  glycoprotein family, which are 
normally expressed on granulocytes and monocytes. Treatment with combina- 
tions of anti-aL, aM, and t3 mAb reproduces these functional abnormalities in 
normal granulocytes (14-16, 39). Interestingly, a latent pool of Mac-1 was found 
in healthy adult but not in patient granulocytes, which was mobilized to the cell 
surface in  response to the chemoattractants and secretagogues f-Met-Leu-Phe 
and  C5a.  Since  /3  subunit  expression  was  increased on  healthy granulocytes, 
p 150,95 may also be up-regulated, but there was only a slight increase in LFA- 
1, as shown with anti-aL mAb. Lack of up-regulation of these molecules may be 
related to  the failure of patients'  granulocytes to  hyperadhere in  response  to 
chemoattractants (14).  Since adherence is necessary for chemotaxis, adherence 
abnormalities could explain the failure of patients'  cells to chemotact despite 
normal bipolarization (14), and may lead to the absence of normal pus formation 
at sites of infection. 
Although lymphocytes express only one member of the family, LFA- 1, increas- 
ing evidence supports the clinical pathologic importance of lymphoid cell dys- 
function in this disorder. Patient 2 of this report died of an overwhelming viral 
(pico RNA virus) respiratory infection. Impaired proliferative responses of pa- 
tient  cells  to  PHA  (10-25%  of normal  values)  and  diminished  cytolytic  T 
lymphocyte and natural killing activity have been documented among studies in 
our patients (16, 40) as well as in a patient reported elsewhere (39). Interestingly, 
the PHA responses and cytotoxic killing by lymphocytes of patients  1, 2, and 4 
are even further decreased by anti-LFA-1  mAb, suggesting that even the small 
amounts of LFA-1  present on patient cells can contribute to their functional 
responsiveness (40). 
Summary 
Leukocyte surface glycoproteins that  share a  common /3 subunit have been 
found to  be congenitally deficient in  three  unrelated patients  with recurring 
bacterial  infection. The  glycoproteins, Mac-l,  LFA-1,  and p150,95,  have the 
subunit compositions aM/3,  aL/3,  and aX/3,  respectively. Using subunit-specific 
monoclonal antibodies,  both  the aM  and /3 subunits of Mac-l,  the aL  and 13 
subunits of LFA-1, and at the least the/3 subunit of p150,95,  were found to be 
deficient at  the  cell  surface  by  the  techniques  of immunofluorescence flow 
cytometry, radioimmunoassay, and immunoprecipitation. A latent pool of Mac- 
1 that can be expressed on granulocyte surfaces in response to secretory stimuli, 
such as f-Met-Leu-Phe, was also lacking in patients. Deficiency was found on all 
leukocytes tested, including granulocytes, monocytes, and T  and B lymphocytes. 
Quantitation  by  immunofluorescence cytometry of subunits  on  granulocytes 
from parents of these patients and of a fourth deceased patient showed approx- 
imately half-normal surface expression, and, together with data on other siblings 
and  a  family  with  an  affected  father  and  children,  demonstrate  autosomal 
recessive inheritance. Deficiency appears to be quantitative rather than qualita- 1916  INHERITED  DEFICIENCY OF  Mac-l,  LFA-1,  p150,95 
tive,  with  two  patients  expressing  -0.5%  and  one  patient  ~5%  of  normal 
amounts. The latter patient had a/3 complexes on the cell surface detectable by 
immunoprecipitation. Biosynthesis expei'iments showed the presence of normal 
amounts of a'L intracellular precursor in lymphoid lines of all three  patients. 
Together  with  surface  deficiency of three  molecules  that  share  a  common  /3 
subunit but have differing a  subunits, this suggests the primary deficiency is of 
the/3 subunit. The lack of maturation of a'L to aL and the deficiency of the a 
subunits at the cell surface and in latent pools suggests that association with the 
/3 subunit is required for a  subunit processing and transport to the cell surface 
or  to  latent pools.  The  molecular basis  of this disease  is discussed in  light of 
adhesion-related functional abnormalities in patients' leukocytes and the block- 
ade of similar functions in healthy cells by monoclonal antibodies. 
Received  for publication 7 August  1984. 
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